Wall Street is sniffing cautiously at Blue Apron’s stock. Shares of the online meal-kit delivery service, trading under the symbol “APRN,” rose nearly 6 percent to $10.55 in their Thursday debut on the New York Stock Exchange — a slight bounce from their sharply lowered IPO price. The New York-based tech unicorn late Wednesday had...
NYS Entity Status
NYS Filing Date
MAY 20, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - BLUE DIAMOND ROSE INC.
AROUND THE WEB
- Blue Apron shares up slightly after IPO price gets slashed
By Carleton English, Jacob Sonenshine - Thursday Jun 29, 2017
- NY Times sees jump in digital subscription revenue
By Reuters - Thursday Jul 27, 2017
The New York Times said on Thursday its digital subscription revenue overtook print advertising revenue for the first time — a key milestone in the 166-year old publisher’s efforts to transform itself into a digital media powerhouse. The company’s shares rose as much as 7 percent to their highest since the 2008 financial crisis as...
- Calvin Harris to perform at Rihanna's Diamond Ball charity
By MESFIN FEKADU, AP Music Writer - Wednesday Aug 16, 2017
NEW YORK (AP) — The writer and producer of Rihanna's hit "We Found Love" is set to perform at her charity event in New York next month.Rihanna said Wednesday that Scottish DJ-producer Calvin Harris will join fellow performer Kendrick Lamar and host Dave Chappelle on Sept. 14 for her third Diamond Ball.
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Taylor Swift’s diamond bath cost more than $10M
By Julie Gordon - Tuesday Aug 29, 2017
It turns out the bathtub full of diamonds in Swift's new "Look What You Made Me Do" music video were authentic, on loan from celebrity jeweler Neil Lane.
- Diamonds just got even more valuable
By News.com.au - Monday Jul 3, 2017
Diamonds just got much more valuable. Thanks to Australian research, they will soon become “lenses” offering a powerful view of individual molecules and atoms. The ability to do this is at the heart of modern drug and materials research. But current techniques rely on very large and power hungry devices that offer an averaged impression...